688658 悦康药业
已收盘 04-16 15:00:01
资讯
新帖
简况
龙虎榜 | 消闲派、T王抢筹9天7板中旗新材,涪陵广场路撤离湖南黄金超1.4亿
格隆汇 · 04-14 10:20
龙虎榜 | 消闲派、T王抢筹9天7板中旗新材,涪陵广场路撤离湖南黄金超1.4亿
【科创板收评】午后盘面震荡回落,科创50收涨0.25%,医药板块反复活跃
犀牛之星 · 04-14 07:15
【科创板收评】午后盘面震荡回落,科创50收涨0.25%,医药板块反复活跃
【A股午评:创业板指半日涨0.82% 全市场超4800只个股上涨】A股三大指数今日集体上涨,截至午盘,沪指涨0.86%,深成指涨0.91%,创业板指涨0.82%,北证50指数涨2.33%。全市场半日成交额8621亿元,较上日放量648亿元。全市场超4800只个股上涨。板块题材上,海南自贸区、互联网电商、露营经济、零售板块涨幅居前;转基因、白酒板块跌幅居前。盘面上,跨境电商板块掀涨停潮,三态股份、生意宝、南极电商、龙头股份、跨境通、中源家居等多股涨停。海南本地股领涨,康芝药业、海马汽车、京粮控股、海汽集团、海南海药涨停。大消费方向反复活跃,国芳集团7连板,岭南控股、茂业商业、南宁百货、绝味食品、三江购物涨停。创新药概念活跃,一品红、悦康药业、葫芦娃涨停。
金融界 · 04-14 03:39
【A股午评:创业板指半日涨0.82% 全市场超4800只个股上涨】A股三大指数今日集体上涨,截至午盘,沪指涨0.86%,深成指涨0.91%,创业板指涨0.82%,北证50指数涨2.33%。全市场半日成交额8621亿元,较上日放量648亿元。全市场超4800只个股上涨。板块题材上,海南自贸区、互联网电商、露营经济、零售板块涨幅居前;转基因、白酒板块跌幅居前。盘面上,跨境电商板块掀涨停潮,三态股份、生意宝、南极电商、龙头股份、跨境通、中源家居等多股涨停。海南本地股领涨,康芝药业、海马汽车、京粮控股、海汽集团、海南海药涨停。大消费方向反复活跃,国芳集团7连板,岭南控股、茂业商业、南宁百货、绝味食品、三江购物涨停。创新药概念活跃,一品红、悦康药业、葫芦娃涨停。
异动快报:悦康药业(688658)4月14日11点2分触及涨停板
证券之星 · 04-14 03:05
异动快报:悦康药业(688658)4月14日11点2分触及涨停板
科创医药指数ETF涨逾1.5%,悦康药业涨超19%,机构:看好2025年医药行业的投资机会
21世纪经济报道 · 04-14 03:03
科创医药指数ETF涨逾1.5%,悦康药业涨超19%,机构:看好2025年医药行业的投资机会
A股化学制药板块走高,一品红、悦康药业涨超10%,哈三联、奥赛康、益方生物、海创药业、盟科药业等跟涨。
美港电讯 · 04-14 01:56
A股化学制药板块走高,一品红、悦康药业涨超10%,哈三联、奥赛康、益方生物、海创药业、盟科药业等跟涨。
【创新药概念反复活跃,一品红涨超10%续创历史新高】一品红涨超10%,股价续创历史新高,东诚药业涨停,悦康药业、科兴制药、智翔金泰、前沿生物、热景生物、百济神州等涨幅靠前。
金融界 · 04-14 01:55
【创新药概念反复活跃,一品红涨超10%续创历史新高】一品红涨超10%,股价续创历史新高,东诚药业涨停,悦康药业、科兴制药、智翔金泰、前沿生物、热景生物、百济神州等涨幅靠前。
【化学制药板块走高 一品红、悦康药业涨超10%】化学制药板块走高,一品红、悦康药业涨超10%,哈三联、奥赛康、益方生物、海创药业、盟科药业等跟涨。
金融界 · 04-14 01:55
【化学制药板块走高 一品红、悦康药业涨超10%】化学制药板块走高,一品红、悦康药业涨超10%,哈三联、奥赛康、益方生物、海创药业、盟科药业等跟涨。
悦康药业新提交“悦康慧泰”、“悦康智创泰”等6件商标注册申请
证券之星 · 02-28
悦康药业新提交“悦康慧泰”、“悦康智创泰”等6件商标注册申请
2月28日悦康药业跌8.86%,富国精准医疗混合A基金重仓该股
证券之星 · 02-28
2月28日悦康药业跌8.86%,富国精准医疗混合A基金重仓该股
悦康药业大跌5% 业绩快报营收净利双降
智选洞察 · 02-28
悦康药业大跌5% 业绩快报营收净利双降
悦康药业(688658.SH)2024年度净利润1.24亿元 同比下降33.05%
智通财经 · 02-27
悦康药业(688658.SH)2024年度净利润1.24亿元 同比下降33.05%
悦康药业2024年业绩快报:归母净利润同比降33.05%
财中社 · 02-27
悦康药业2024年业绩快报:归母净利润同比降33.05%
AI+医疗行业深度:AI+医药:势不可挡,未来已至
中邮证券 · 02-19
AI+医疗行业深度:AI+医药:势不可挡,未来已至
【悦康药业新设子公司 含化妆品零售业务 】 公开资料显示,近日,杭州悦康信诚医药有限责任公司成立,法定代表人为于伟仕,注册资本2000万元,经营范围包含:消毒器械销售;食品互联网销售;化妆品批发;化妆品零售等。股权数据显示,该公司由悦康药业全资持股。
金融界 · 02-19
【悦康药业新设子公司 含化妆品零售业务 】 公开资料显示,近日,杭州悦康信诚医药有限责任公司成立,法定代表人为于伟仕,注册资本2000万元,经营范围包含:消毒器械销售;食品互联网销售;化妆品批发;化妆品零售等。股权数据显示,该公司由悦康药业全资持股。
悦康药业新设子公司,含化妆品零售业务
企查查财经 · 02-17
悦康药业新设子公司,含化妆品零售业务
悦康药业02月12日遭主力抛售1262万元
市场透视 · 02-12
悦康药业02月12日遭主力抛售1262万元
医药行业:从摩根大通医疗健康大会看生物创新药管线,关注ADC、双特异性抗体、细胞与基因治疗
研报虎 · 02-11
医药行业:从摩根大通医疗健康大会看生物创新药管线,关注ADC、双特异性抗体、细胞与基因治疗
悦康药业(688658)2月10日主力资金净买入2296.11万元
证券之星 · 02-11
悦康药业(688658)2月10日主力资金净买入2296.11万元
加载更多
公司概况
公司名称:
悦康药业集团股份有限公司
所属行业:
医药制造业
上市日期:
2020-12-24
主营业务:
悦康药业集团股份有限公司的主营业务涵盖药品研发,制造,流通销售全产业链条,具备原料,辅料,制剂全产业链的生产能力;产品适应症包括心脑血管,糖尿病,消化系统,抗肿瘤,抗病毒,生殖健康等多个治疗领域,聚焦慢病以及专科治疗领域;产品类型涵盖化药,中药两大类型;产品剂型涵盖注射剂,冻干粉针剂,片剂,胶囊剂等多种剂型。公司实力雄厚,连续多年入选工信部医药工业百强和中国医药研发产品线最佳工业企业。公司“奥美拉唑系列产品产业化与国际化的关键技术开发项目”、“化学药物晶型关键技术体系的建立与应用”先后获得国家科学技术进步二等奖。
发行价格:
24.36
{"stockData":{"symbol":"688658","market":"SH","secType":"STK","nameCN":"悦康药业","latestPrice":16.38,"timestamp":1744786801000,"preClose":16.34,"halted":0,"volume":18998829,"delay":0,"changeRate":0.0024,"floatShares":450000000,"shares":450000000,"eps":0.1392,"marketStatus":"已收盘","change":0.04,"latestTime":"04-16 15:00:01","open":16.39,"high":16.95,"low":16.03,"amount":312000000,"amplitude":0.0563,"askPrice":16.39,"askSize":25,"bidPrice":16.38,"bidSize":447,"shortable":0,"etf":0,"ttmEps":0.1392,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1744853400000},"marketStatusCode":5,"adr":0,"adjPreClose":16.34,"symbolType":"stock_kcb","openAndCloseTimeList":[[1744767000000,1744774200000],[1744779600000,1744786800000]],"highLimit":17.97,"lowLimit":14.71,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":450000000,"isCdr":false,"pbRate":2.06,"roa":"--","peRate":117.672414,"roe":"3.46%","epsLYR":0.28,"committee":0.529332,"marketValue":7371000000,"turnoverRate":0.0422,"status":0,"afterMarket":{"amount":0,"volume":0,"close":16.38,"buyVolume":0,"sellVolume":0,"time":1744788838029,"indexStatus":"已收盘 04-16 15:30:00","preClose":16.34},"floatMarketCap":7371000000},"requestUrl":"/m/hq/s/688658","defaultTab":"news","newsList":[{"id":"2527134634","title":"龙虎榜 | 消闲派、T王抢筹9天7板中旗新材,涪陵广场路撤离湖南黄金超1.4亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2527134634","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2527134634?lang=zh_cn&edition=full","pubTime":"2025-04-14 18:20","pubTimestamp":1744626034,"startTime":"0","endTime":"0","summary":"今日龙虎榜净买入额前三为湖南黄金、天和磁材、悦康药业","market":"us","thumbnail":"https://img3.gelonghui.com/35d7c-d2e9992d-15ef-4f42-b75a-1ee12b611dd4.jpg?guru_height=852&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/35d7c-d2e9992d-15ef-4f42-b75a-1ee12b611dd4.jpg?guru_height=852&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/2040662","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK0070","002165","BK0039","BK0086","BK0239","BK0004","BK0229","BK0209","BK0057","BK0127","600697","BK0138","BK0242","603072","BK0050","688658","BK0214","002286","BK0028","BK0238","BK0182","002155"],"gpt_icon":0},{"id":"2527086909","title":"【科创板收评】午后盘面震荡回落,科创50收涨0.25%,医药板块反复活跃","url":"https://stock-news.laohu8.com/highlight/detail?id=2527086909","media":"犀牛之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2527086909?lang=zh_cn&edition=full","pubTime":"2025-04-14 15:15","pubTimestamp":1744614900,"startTime":"0","endTime":"0","summary":"犀牛之星4月14日讯,今日科创板整体冲高回落,指数早间震荡拉升,午后小幅震荡回落涨幅收窄,科创50收涨0.25%,报1014.28点。截至当日收市,共402只个股收涨,176只个股收跌。涨幅排行方面,悦康药业涨19.99%居首,科兴制药涨16.83%次之。跌幅排行方面,ST观典 跌9.24%居首,唯捷创芯 跌5.33%次之。成交额方面,科创板全天共成交1040.61亿元,寒武纪 成交55.42居首,中芯国际 成交34.78亿元次之。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041415172494d4b5c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041415172494d4b5c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["000688","159938","000688.SH","159982","BK0242","688658","688136"],"gpt_icon":0},{"id":"2527929619","title":"【A股午评:创业板指半日涨0.82% 全市场超4800只个股上涨】A股三大指数今日集体上涨,截至午盘,沪指涨0.86%,深成指涨0.91%,创业板指涨0.82%,北证50指数涨2.33%。全市场半日成交额8621亿元,较上日放量648亿元。全市场超4800只个股上涨。板块题材上,海南自贸区、互联网电商、露营经济、零售板块涨幅居前;转基因、白酒板块跌幅居前。盘面上,跨境电商板块掀涨停潮,三态股份、生意宝、南极电商、龙头股份、跨境通、中源家居等多股涨停。海南本地股领涨,康芝药业、海马汽车、京粮控股、海汽集团、海南海药涨停。大消费方向反复活跃,国芳集团7连板,岭南控股、茂业商业、南宁百货、绝味食品、三江购物涨停。创新药概念活跃,一品红、悦康药业、葫芦娃涨停。","url":"https://stock-news.laohu8.com/highlight/detail?id=2527929619","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2527929619?lang=zh_cn&edition=full","pubTime":"2025-04-14 11:39","pubTimestamp":1744601994,"startTime":"0","endTime":"0","summary":"A股三大指数今日集体上涨,截至午盘,沪指涨0.86%,深成指涨0.91%,创业板指涨0.82%,北证50指数涨2.33%。全市场半日成交额8621亿元,较上日放量648亿元。全市场超4800只个股上涨。板块题材上,海南自贸区、互联网电商、露营经济、零售板块涨幅居前;转基因、白酒板块跌幅居前。盘面上,跨境电商板块掀涨停潮,三态股份、生意宝、南极电商、龙头股份、跨境通、中源家居等多股涨停。海南本地股领涨,康芝药业、海马汽车、京粮控股、海汽集团、海南海药涨停。大消费方向反复活跃,国芳集团7连板,岭南控股、茂业商业、南宁百货、绝味食品、三江购物涨停。创新药概念活跃,一品红、悦康药业、葫芦娃涨停。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/14113949515220.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0260","BK0239","600828","160636","000997.SH","300723","BK0264","06978","399300","BK0247","159982","605199","BK0173","601086","603517","BK0042","000566","BK0065","BK0186","BK0209","002127","159792","399006","601116","603069","BK0253","688658","002095","002640","BK0164","BK0055","159992","BK0170","BK0060","BK0217","603709","000505","BK0028","000524","301558","BK0174","BK0095","600712","300086","000572","BK0196","BK0238","600630","BK0063"],"gpt_icon":0},{"id":"2527928057","title":"异动快报:悦康药业(688658)4月14日11点2分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2527928057","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2527928057?lang=zh_cn&edition=full","pubTime":"2025-04-14 11:05","pubTimestamp":1744599919,"startTime":"0","endTime":"0","summary":"证券之星4月14日盘中消息,11点2分悦康药业触及涨停板。目前价格16.15,上涨19.99%。其所属行业化学制药目前上涨。领涨股为一品红。该股为创新药,医药,中药概念热股,当日创新药概念上涨3.29%,医药概念上涨2.75%,中药概念上涨2.7%。4月11日的资金流向数据方面,主力资金净流出550.79万元,占总成交额5.63%,游资资金净流入1011.63万元,占总成交额10.34%,散户资金净流出460.85万元,占总成交额4.71%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025041400008438.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688658","BK0239"],"gpt_icon":0},{"id":"2527926042","title":"科创医药指数ETF涨逾1.5%,悦康药业涨超19%,机构:看好2025年医药行业的投资机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2527926042","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2527926042?lang=zh_cn&edition=full","pubTime":"2025-04-14 11:03","pubTimestamp":1744599829,"startTime":"0","endTime":"0","summary":"4月14日,A股三大指数集体上涨,上证科创板生物医药指数上涨1.37%;该指数成分股中,悦康药业上涨超19%,智翔金泰上涨超9%,三生国健上涨超6%。相关ETF方面,科创医药指数ETF截至发稿上涨超1.5%,涨跌幅暂居同标的产品第1名。该ETF最新流通份额为3.65亿份,最新流通规模为3.49亿元。中信建投表示,继续看好2025年医药行业的投资机会。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504141123049737092f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504141123049737092f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","588700","688658"],"gpt_icon":0},{"id":"2527594614","title":"A股化学制药板块走高,一品红、悦康药业涨超10%,哈三联、奥赛康、益方生物、海创药业、盟科药业等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2527594614","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2527594614?lang=zh_cn&edition=full","pubTime":"2025-04-14 09:56","pubTimestamp":1744595818,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1574","01477","688382","159982","688302","002900","688658","688373","300723","BK0028","399300","BK1191","BK0239","002755"],"gpt_icon":0},{"id":"2527946447","title":"【创新药概念反复活跃,一品红涨超10%续创历史新高】一品红涨超10%,股价续创历史新高,东诚药业涨停,悦康药业、科兴制药、智翔金泰、前沿生物、热景生物、百济神州等涨幅靠前。","url":"https://stock-news.laohu8.com/highlight/detail?id=2527946447","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2527946447?lang=zh_cn&edition=full","pubTime":"2025-04-14 09:55","pubTimestamp":1744595733,"startTime":"0","endTime":"0","summary":"一品红涨超10%,股价续创历史新高,东诚药业涨停,悦康药业、科兴制药、智翔金泰、前沿生物、热景生物、百济神州等涨幅靠前。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/14095549514272.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","BK1583","688235","688136","300723","BK1574","159992","BK4139","688658","LU1969619763.USD","06978","ONC","LU0588546209.SGD","BK1500","BK0239","688068","688221","688443","BK1588","06160","LU0307460666.USD","LU2328871848.SGD","002675"],"gpt_icon":0},{"id":"2527946700","title":"【化学制药板块走高 一品红、悦康药业涨超10%】化学制药板块走高,一品红、悦康药业涨超10%,哈三联、奥赛康、益方生物、海创药业、盟科药业等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2527946700","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2527946700?lang=zh_cn&edition=full","pubTime":"2025-04-14 09:55","pubTimestamp":1744595715,"startTime":"0","endTime":"0","summary":"化学制药板块走高,一品红、悦康药业涨超10%,哈三联、奥赛康、益方生物、海创药业、盟科药业等跟涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/14095549514281.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","688658","BK1191","002900","002755","688302","BK1574","688382","01477","688373","BK0028","300723"],"gpt_icon":0},{"id":"2516888300","title":"悦康药业新提交“悦康慧泰”、“悦康智创泰”等6件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2516888300","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516888300?lang=zh_cn&edition=full","pubTime":"2025-03-01 06:20","pubTimestamp":1740781241,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示,近日悦康药业集团股份有限公司新提交“悦康慧泰”、“悦康智创泰”等6件商标注册申请。商标申请详情如下:今年以来悦康药业集团股份有限公司新申请注册商标7件,截止目前公司共持有注册商标1358件,另有23件商标尚在注册申请中。数据来源:企查查以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030100010034.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688658","BK0239"],"gpt_icon":0},{"id":"2514798312","title":"2月28日悦康药业跌8.86%,富国精准医疗混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2514798312","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514798312?lang=zh_cn&edition=full","pubTime":"2025-02-28 16:32","pubTimestamp":1740731564,"startTime":"0","endTime":"0","summary":"证券之星消息,2月28日悦康药业跌8.86%,收盘报14.92元,换手率4.74%,成交量21.31万手,成交额3.25亿元。重仓悦康药业的公募基金请见下表:该股最近90天内共有1家机构给出评级,买入评级1家;过去90天内机构目标均价为25.52。根据2024基金年报公募基金重仓股数据,重仓该股的公募基金共6家,其中持有数量最多的公募基金为富国精准医疗混合A。富国精准医疗混合A目前规模为35.22亿元,最新净值2.4203,较上一交易日上涨2.54%,近一年上涨15.63%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022800029073.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688658"],"gpt_icon":0},{"id":"2514660093","title":"悦康药业大跌5% 业绩快报营收净利双降","url":"https://stock-news.laohu8.com/highlight/detail?id=2514660093","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514660093?lang=zh_cn&edition=full","pubTime":"2025-02-28 09:30","pubTimestamp":1740706242,"startTime":"0","endTime":"0","summary":"消息解读悦康药业2月27日晚间披露2024年业绩快报,公司实现营业收入37.81亿元,同比下降9.9%;归母净利润1.24亿元,同比下降33.05%;扣非净利润1.11亿元,同比下降16.33%;基本每股收益0.28元,加权平均净资产收益率为3.46%。最新财报显示,今年三季报,悦康药业实现营业收入29.92亿元,同比增长1.15%,净利润为2.10亿元,同比增长37.73%,基本每股收益为0.47元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228093150a2571165&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228093150a2571165&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688658"],"gpt_icon":0},{"id":"2514487460","title":"悦康药业(688658.SH)2024年度净利润1.24亿元 同比下降33.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514487460","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514487460?lang=zh_cn&edition=full","pubTime":"2025-02-27 18:31","pubTimestamp":1740652307,"startTime":"0","endTime":"0","summary":"智通财经APP讯,悦康药业(688658.SH)发布2024年度业绩快报,2024年度公司实现营业总收入37.81亿元,较上年同期下降9.90%,实现归属于母公司所有者的净利润1.24亿元,同比下降33.05%。2024年度影响经营业绩的主要因素:受医药市场整体环境及政策影响,公司部分产品竞争持续加剧,以及公司持续加大研发投入和计提资产减值准备所致。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1255437.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688658"],"gpt_icon":0},{"id":"2514827571","title":"悦康药业2024年业绩快报:归母净利润同比降33.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514827571","media":"财中社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514827571?lang=zh_cn&edition=full","pubTime":"2025-02-27 16:41","pubTimestamp":1740645709,"startTime":"0","endTime":"0","summary":"2月27日,悦康药业发布公告,2024年度业绩快报显示,公司的营业总收入为37.81亿元,较上年同期下降9.9%。营业利润为1.59亿元,同比下降31.37%。基本每股收益为0.28元,较上年同期的0.41元下降31.71%。此外,公司的总资产为57.38亿元,较年初下降2.93%,归母权益为35.78亿元,较年初下降0.28%。公告指出,业绩下滑主要受到医药市场环境及政策影响,以及公司产品竞争加剧的影响。2024年前三季度,悦康药业实现收入29.92亿元,归母净利润2.1亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022716452796324b2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022716452796324b2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688658"],"gpt_icon":0},{"id":"2512212496","title":"AI+医疗行业深度:AI+医药:势不可挡,未来已至","url":"https://stock-news.laohu8.com/highlight/detail?id=2512212496","media":"中邮证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512212496?lang=zh_cn&edition=full","pubTime":"2025-02-19 15:04","pubTimestamp":1739948697,"startTime":"0","endTime":"0","summary":"投资要点“AI+医疗”解决方案全球市场有望突破千亿美元,有望进入到商业化加速阶段。“AI+医疗”行业人工智能解决方案的全球市场规模预计将由2022年的137亿美元增至2030年的1,553亿美元,CAGR为35.5%,行业存在爆发式增长机会。政策面上,国内宏观政策利好AI制药,医疗AI三类证审批加速。我们认为“AI+医疗”有望应用于药物研发、癌症诊断、医学影像、手术机器人等领域,行业或迎来巨变。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219150422a24b831f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219150422a24b831f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603351","688578","688505","605177","600624","688235","600062","605116","688176","688566","605507","603367","600200","603520","601089","688062","688553","688302","688247","688602","603669","600812","688658","600513","603538","600613","BK0188","688189","603676","688076","688091","688166","688356","688428","BK0028","688117","600079","600488","603207","BK0239","688690","688221","BK0175","600216","688321","688513","688373","600774","603229","600276","BK0185","600196","603168","603811","688266","688192","600664","688197","159891","688382","688758","600789","600521","BK0010","600851","600380","159938","688799","600420"],"gpt_icon":0},{"id":"2512149057","title":"【悦康药业新设子公司 含化妆品零售业务 】 公开资料显示,近日,杭州悦康信诚医药有限责任公司成立,法定代表人为于伟仕,注册资本2000万元,经营范围包含:消毒器械销售;食品互联网销售;化妆品批发;化妆品零售等。股权数据显示,该公司由悦康药业全资持股。","url":"https://stock-news.laohu8.com/highlight/detail?id=2512149057","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512149057?lang=zh_cn&edition=full","pubTime":"2025-02-19 11:11","pubTimestamp":1739934693,"startTime":"0","endTime":"0","summary":"公开资料显示,近日,杭州悦康信诚医药有限责任公司成立,法定代表人为于伟仕,注册资本2000万元,经营范围包含:消毒器械销售;食品互联网销售;化妆品批发;化妆品零售等。股权数据显示,该公司由悦康药业全资持股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/19111148249887.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["159792","688658","165519","BK0239","160636"],"gpt_icon":0},{"id":"2512258995","title":"悦康药业新设子公司,含化妆品零售业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2512258995","media":"企查查财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512258995?lang=zh_cn&edition=full","pubTime":"2025-02-17 11:44","pubTimestamp":1739763891,"startTime":"0","endTime":"0","summary":"企查查APP显示,近日,杭州悦康信诚医药有限责任公司成立,法定代表人为于伟仕,注册资本2000万元,经营范围包含:消毒器械销售;食品互联网销售;化妆品批发;化妆品零售等。企查查股权穿透显示,该公司由悦康药业(688658)全资持股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217114628a248aaac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217114628a248aaac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688658","BK0239"],"gpt_icon":0},{"id":"2510341497","title":"悦康药业02月12日遭主力抛售1262万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510341497","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510341497?lang=zh_cn&edition=full","pubTime":"2025-02-12 15:21","pubTimestamp":1739344897,"startTime":"0","endTime":"0","summary":"02月12日, 悦康药业股价涨0.19%,报收15.55元,成交金额1.01亿元,换手率1.46%,振幅1.93%,量比0.73。悦康药业今日主力资金净流出1262万元,上一交易日主力净流出326万元。该股近5个交易日上涨5.35%,主力资金累计净流入1953万元;近20日主力资金累计净流出296万元,其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212153922a242e89e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212153922a242e89e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688658"],"gpt_icon":0},{"id":"2510827757","title":"医药行业:从摩根大通医疗健康大会看生物创新药管线,关注ADC、双特异性抗体、细胞与基因治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2510827757","media":"研报虎","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510827757?lang=zh_cn&edition=full","pubTime":"2025-02-11 13:59","pubTimestamp":1739253565,"startTime":"0","endTime":"0","summary":"2025年第四十三届摩根大通医疗健康年会盛大召开。我们从本次会议的热点一窥行业创新升级的重点方向,关注抗体偶联药物、双特异性抗体、细胞与基因治疗等生物创新药领域的最新进展。2025JPM大会展示的ADC药物多达数十款,基本为第三代产品,面向肺癌、乳腺癌、肺癌等高发实体瘤,涌现出一大批创新前沿的生物技术公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211140710abca815b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211140710abca815b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688266","603676","603367","159992","605116","688566","BK0012","603207","605177","BK0175","600196","603520","600513","688302","600216","688505","603351","605507","603168","BK0239","688247","159760","688373","BK0096","BK0183","600200","688690","688235","688356","600624","688658","BK0196","688197","603229","600521","BK0188","600488","600267","688428","600380","600420","688513","600664","688221","688176","600613","600079","603811","688506","688117","688799","600276","601089","603538","688578","603669","600774","603707","600062","BK0187","688553","688189","BK0060","688321","688602","BK0028"],"gpt_icon":0},{"id":"2510084856","title":"悦康药业(688658)2月10日主力资金净买入2296.11万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510084856","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510084856?lang=zh_cn&edition=full","pubTime":"2025-02-11 08:41","pubTimestamp":1739234499,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2025年2月10日收盘,悦康药业报收于15.71元,上涨4.25%,换手率2.95%,成交量13.3万手,成交额2.07亿元。近5日资金流向一览见下表:悦康药业融资融券信息显示,融资方面,当日融资买入2602.34万元,融资偿还2499.97万元,融资净买入102.37万元,连续3日净买入累计684.26万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021100006219.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688658"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1744795649082,"stockEarnings":[{"period":"1week","weight":0.2706},{"period":"1month","weight":0.0981},{"period":"3month","weight":0.1207},{"period":"6month","weight":-0.3035},{"period":"1year","weight":0.1248},{"period":"ytd","weight":0.1339}],"compareEarnings":[{"period":"1week","weight":0.0388},{"period":"1month","weight":-0.0444},{"period":"3month","weight":0.0126},{"period":"6month","weight":0.031},{"period":"1year","weight":0.0688},{"period":"ytd","weight":-0.0251}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"悦康药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"14382人(较上一季度减少0.70%)","perCapita":"31289股","listingDate":"2020-12-24","address":"北京市大兴区北京经济技术开发区宏达中路6号","registeredCapital":"45000万元","survey":" 悦康药业集团股份有限公司的主营业务涵盖药品研发,制造,流通销售全产业链条,具备原料,辅料,制剂全产业链的生产能力;产品适应症包括心脑血管,糖尿病,消化系统,抗肿瘤,抗病毒,生殖健康等多个治疗领域,聚焦慢病以及专科治疗领域;产品类型涵盖化药,中药两大类型;产品剂型涵盖注射剂,冻干粉针剂,片剂,胶囊剂等多种剂型。公司实力雄厚,连续多年入选工信部医药工业百强和中国医药研发产品线最佳工业企业。公司“奥美拉唑系列产品产业化与国际化的关键技术开发项目”、“化学药物晶型关键技术体系的建立与应用”先后获得国家科学技术进步二等奖。","listedPrice":24.36},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.1","shortVersion":"4.33.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"悦康药业(688658)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供悦康药业(688658)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"悦康药业,688658,悦康药业股票,悦康药业股票老虎,悦康药业股票老虎国际,悦康药业行情,悦康药业股票行情,悦康药业股价,悦康药业股市,悦康药业股票价格,悦康药业股票交易,悦康药业股票购买,悦康药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"悦康药业(688658)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供悦康药业(688658)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}